Rx (Prescription Medicine)
USD $ 603.00
Priunta 150毫克注射液，其活性成分为培美曲塞二钠，用于治疗特定类型的肺癌和间皮瘤。它由医疗专业人员作为化疗方案的一部分进行静脉注射。
Priunta 150毫克注射液是一种重要药物，含有活性成分培美曲塞二钠，这是一种强效的抗叶酸抗肿瘤剂。它主要与其他化疗药物联合使用，用于治疗某些类型的非小细胞肺癌（NSCLC）和恶性胸膜间皮瘤。培美曲塞通过干扰癌细胞的生长发挥作用，随后癌细胞会被身体清除。这种注射液由合格的医疗专业人员进行静脉注射。患者应告知医生任何既往病史，特别是肾脏问题，以及他们正在服用的任何其他药物。严格遵守规定的剂量和时间表至关重要。将注射液在室温下储存，避光防潮。如果溶液变色或含有颗粒，请勿使用。始终咨询您的医疗保健提供者，以获取个性化的医疗建议和治疗方案。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type |
未库存此 exact 强度的其他品牌，因此这些是其他强度的 Particles. 未经开方医生建议，请勿更改剂量。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
